NFX & Merck Back Pepper Bio, the 'Google Maps for Drug Discovery,' with $6.5M to Streamline R&D
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Pepper Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Newark, N.J. (PRWEB) December 16, 2022 -- On Friday December 16, Merck (NYSE: MRK) today announced the launch of their first biopharmaceutical cohort through
There’s a clear pain point when it comes to drug discovery: Depending on which study you cite, creating an approved drug costs anywhere from $985 million to $2.6 billion. And R&D returns have rebounded to only about 2.5% in 2020, up from a low of 1.6% in 2019. Not to mention the fact that drugs […]